What does Werewolf Therapeutics, Inc. do?
Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for…
What is Werewolf Therapeutics, Inc.'s P/E and P/B ratio?
Werewolf Therapeutics, Inc. has a P/E ratio of -1.4 and a P/B ratio of 3.01.
What is Werewolf Therapeutics, Inc.'s debt-to-equity ratio?
Werewolf Therapeutics, Inc. has a debt-to-equity ratio of 1.52.
How much does Werewolf Therapeutics, Inc. owe compared with what it owns?
Werewolf Therapeutics, Inc. owes $0.33 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Werewolf Therapeutics, Inc.'s Positivity rank?
Werewolf Therapeutics, Inc. is ranked #5,602 of 6,774 companies globally and #3,076 of 4,000 in United States on PositoAI, with a Positivity Score of 16,679.
Does Werewolf Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Yes. Werewolf Therapeutics, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 06 Feb 2026). It has no yellow flags.
Where can I read the latest news about Werewolf Therapeutics, Inc.?
Recent headlines about Werewolf Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Werewolf Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Werewolf Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.